Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
Breast Augmentation Revision:  A Patient Example

Breast Augmentation Revision: A Patient Example

Breast Augmentation Revision:  A Patient Example

November 11, 2013

Natrelle Breast ImplantsI recently had the pleasure of seeing a young woman who had silicone breast implants placed by another Plastic Surgery but was simply not happy with the results.  She initially had silicone gel implants under the muscle through an incision under her breasts but soon after her surgery noticed that one side had dropped. Her Plastic surgeon performed a procedure to tighten the scar tissue capsule on that side to try and elevate the implant but this procedure left her with puckering to both the lateral and medial edges and the result now looked even worse than it did before the procedure.   When she saw me, she was frustrated about the appearance of her breasts and the relative asymmetry that had resulted and wanted to discuss her options.  On examination, I noted that one side was puckered giving this breast a very distorted and unnatural look.  And because the capsule had been tightened so much, there was distortion of the implant itself causing one edge to bulge out and creating a palpable point on her skin.  My concern was that she not only had a sub-optimal result but also that over time this puckering would actually cause erosion of her overlying skin and eventually lead to exposure of the implant itself.  She also expressed interest in a slight upsize to give her more fullness to the upper pole of her breasts. My recommendation was that we do the following:

Slide2

  • Replace both implants and modestly upsize
  • Remove the previous capsular sutures to release the puckering
  • Perform a secondary capsular tightening to more optimally position the breast fold
  • Reinforce this repair with an ADM (acellular dermal matrix) graft of Strattice

Slide1She ultimately underwent these procedures followed by taping of the fold and wearing of an underwire bra for 3 months.  She has since been seen in follow-up and is extremely pleased with her results and the more natural appearance of her breasts. I will be posting similar cases in the coming months and look forward to your input.  To learn more, please CLICK HERE to schedule your evaluation, call us at 30.747.6719, or email me directly at drbuford@beautybybuford.com Thanks again for your continued support.  We look forward to hearing from you.

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.